Description
Montiget contains Montelukast and is effective in:
· Prophylaxis and chronic treatment of asthma in patients 12 months
of age and older.
· Relief of symptoms of allergic rhinitis (AR):
– Seasonal allergic rhinitis (SAR) in patients 2 years of age and older.
– Perennial allergic rhinitis (PAR) in patients 6 months of age and
older.
· Acute prevention of exercise-induced bronchoconstriction (EIB) in
patients 15 years of age and older.
Montiget 5mg chewable tablet is effective in pediatric patients 6 to 14 years of age with Asthma or Seasonal/Perennial Allergic Rhinitis: One chewable tablet is taken once daily
